ClinicalTrials.gg
RecruitingNCT07540429ADO IMAGEUpdated Apr 20, 2026

ADOLESCENTS IMAGING USING fMRI: Feasibility Study

An interventional study of functional magnetic resonance imaging (fMRI) in Diagnosis of BPD Based on the DIB-R Clinical Interview for the BPD Group, Diagnosis of ADHD Using the KSADS-PL for the ADHD Group and Absence of Pathology on the CBCL and Ab-DIB for the Healthy Control Group, sponsored by Etablissement Public de la Sante Mentale de la Somme. Recruiting at 1 site in France. Open to female participants aged 12 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Etablissement Public de la Sante Mentale de la Somme · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jun 2024, registered Feb 2026).
  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Non-randomized
Ages
12 Years to 17 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Borderline Personality Disorder with a site in France — 12 open to participants now, 13 under way, none of them phase 3. Borderline Personality Disorder · France.

Planned enrollment
19th of 24
21 · median 72
Started
2024
with 2 others
No phase
20 of 32
9 open now
Primary completion
2027-06
later than 4 of 12 live
Registered
31st of 32
by date

Among the 32 studies in Borderline Personality Disorder with a site in France, this one is the 19th largest by planned enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2024, is one of 20 with no phase, reaches primary completion later than 4 of the 12 other live ones, and was the 31st registered.

Borderline Personality Disorder

279 studies on the registry are indexed under Borderline Personality Disorder; 70 are open to participants now.

Browse Borderline Personality Disorder studies →

Open to participants now

12 of the 32 studies in Borderline Personality Disorder with a site in France are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 49 Borderline Personality Disorder studies recruiting now, 18 (37%) set no upper age limit and 30 (61%) stop at 75 or younger; 7 take children under 18; 11 take healthy volunteers.

This study: 12 Years to 17 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Borderline Personality Disorder with a site in France, or all of them as a file.
02

Study summary

Impaired social cognition and cognitive control associated with borderline personality disorder (BPD) remain less explored. Recent Franco-Canadian study, has shown the feasibility of a neuroimaging tests in Quebec adolescents with BPD. This study aims to increase knowledgements related to neural correlates of BPD and clinical disorders.

03

Conditions studied

  • Diagnosis of BPD Based on the DIB-R Clinical Interview for the BPD Group
  • Diagnosis of ADHD Using the KSADS-PL for the ADHD Group
  • Absence of Pathology on the CBCL and Ab-DIB for the Healthy Control Group
  • All Participants Were Euthymic at the Time of Task Administration

Keywords

  • disturbances in social cognition
  • cognitive control associated
  • borderline personality disorder
  • neuroimaging in adolescent girls
  • child psychiatry
04

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female adolescents meeting DIB-R criteria for BPD group
  • Female adolescents meeting kSADS-PL for ADHD group
  • Female adolescents without any psychologic disorders

Exclusion criteria

Exclusion Criteria:

  • Any medical history with head trauma, chronic neurologic disease, any for fRMI, claustrophobia or pregnancy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
21 participants (estimated)

Study arms

  • Other
    Healthy adolescent girl volunteers

    The participants will follow the same study plan

    Diagnostic Test: functional magnetic resonance imaging (fMRI)

  • Other
    Adolescent girls with borderline personality disorder

    The participants will follow the same study plan

    Diagnostic Test: functional magnetic resonance imaging (fMRI)

  • Other
    Adolescent girls with Attention Deficit Hyperactivity Disorder

    The participants will follow the same study plan

    Diagnostic Test: functional magnetic resonance imaging (fMRI)

Interventions

  • Diagnostic testfunctional magnetic resonance imaging (fMRI)

    Investigators used fMRI to compare patterns of regional brain activation between three groups of adolescents girls: Six female adolescents meeting criteria for BPD, 6 female adolescents meeting criteria of ADHD and 6 female adolescents without psychiatric disorder were recruited.

06

What researchers measure

Primary outcomes

  1. MRI-Acquired Activation Mapping

    Establishment of activation maps by statistical analysis of local signal variations to locate functional regions essential to motor skills and language.

    Time frame: 2 years

Secondary outcomes

  1. Feasibility of this study

    Pilot feasibility study with a small sample size

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Guile JM, Boissel L, Alaux-Cantin S, de La Riviere SG. Borderline personality disorder in adolescents: prevalence, diagnosis, and treatment strategies. Adolesc Health Med Ther. 2018 Nov 23;9:199-210. doi: 10.2147/AHMT.S156565. eCollection 2018. PubMed 30538595 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Jun 2027, 36 months after the start.

Of 106 non-industry interventional studies with no phase under Borderline Personality Disorder, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 54. This study's planned 36 months is close to that.

Counting every sponsor, half of 108 studies reached it within 35 months; a quarter within 24 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2026
First posted
Apr 20, 2026
StartActual
Jun 8, 2024
Primary completionEst.
Jun 8, 2027
CompletionEst.
Dec 31, 2027
Last update
Apr 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07540429
Lead sponsor
Etablissement Public de la Sante Mentale de la Somme
Responsible party
Sponsor
First posted
Apr 20, 2026
Start date
Jun 8, 2024
Primary completion
Jun 8, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 20, 2026

Study contacts

MICHAEL MONET, PhD
Contact
unite.2.recherche@epsm-somme.fr
0322534612
Jean Marc GUILE, Professor
Contact
jmguile@gmail.com
Jean Marc GUILE, Professor
principal investigator · EPSM de la Somme

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion